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Escherichia coli bacteriophage T7 is a founding member of a large clade of podoviruses encoding a
single-subunit RNA polymerase (RNAP). Phages of the family rely on host RNAP for transcription of
early viral genes; viral RNAP transcribes non-early viral genes. T7 and its close relatives encode an
inhibitor of host RNAP, the gp2 protein. Gp2 is essential for phage development and ensures that host
RNAP does not interfere with viral RNAP transcription at late stages of infection. Here, we identify host
RNAP inhibitors encoded by a subset of T7 clade phages related to fKMV phage of Pseudomonas
aeruginosa. We demonstrate that these proteins are functionally identical to T7 gp2 in vivo and in vitro.
The ability of some Pseudomonas phage gp2-like proteins to inhibit RNAP is modulated by N-terminal
domains, which are absent from the T7 phage homolog. This ﬁnding indicates that Pseudomonas phages
may use external or internal cues to initiate inhibition of host RNAP transcription and that gp2-like
proteins from these phages may be receptors of these cues.
& 2012 Elsevier Inc. All rights reserved.Introduction
During the infection of Escherichia coli by bacteriophage T7, only
2% of phage genome corresponding to genetically deﬁned left end
enters the infected cell immediately after the phage attachment
(Garcia and Molineux, 1995; Kemp et al., 2005). The remaining DNA
is brought in by transcription, ﬁrst by E. coli and then by T7 RNAP
(Kemp et al., 2004). The leading part of the genome contains strong
early promoters recognized by the host s70 RNAP holoenzyme
(Es70). Transcription by Es70 from the early promoters causes at
least 7 kbp of the 40 kbp T7 genome to enter the bacterial cell
(Kemp et al., 2004). The mRNAs produced from these promoters code
for several phage proteins involved in the shut-off of host defenses,
such as gp0.3, an antirestriction protein (Studier, 1975; Mark and
Studier, 1981; Walkinshaw et al., 2002), and gp0.7, a protein kinase
that phosphorylates the b0 subunit of host RNAP and affects its
termination properties (Severinova and Severinov, 2006). E. coli RNAP
also transcribes gene 1, which encodes a single-subunit, rifampicin-
resistant viral RNAP. The latter enzyme normally completes thell rights reserved.
Frelinghuysen Road,
. Severinov).genome internalization process by transcription from its own pro-
moters, which are located throughout the genome (Garcia and
Molineux, 1999).
T7 RNAP transcribes the middle and late genes of the phage
(Fig. 1). Genes from the former group mostly code for proteins
involved in phage DNA replication. Genes from the latter group
encode structural proteins of the T7 virion. The product of phage
middle gene 2 is a potent inhibitor of host RNAP (Hesselbach and
Nakada, 1977). Gp2 is a 7 kDa protein that binds to the host
RNAP b0 subunit downstream jaw domain and prevents open
promoter complex formation by Es70 (Nechaev and Severinov,
1999). Gp2 has no effect on transcription by T7 RNAP (LeClerc and
Richardson, 1979).
T7 gene 2 is an essential gene. Analysis of infection of non-
permissive cells by T7 gene 2 amber (T72am) mutants reveals that
the infection is blocked at the stage of packaging of concatemeric
viral DNA into virion heads (LeClerc and Richardson, 1979). The
absence of gp2 can be complemented by treating T72am–infected
cells with rifampicin, an inhibitor of host RNAP, after the onset of
middle gene transcription (Ontell and Nakada, 1980; Mooney et al.,
1980). The result thus suggests that the only essential function of
gp2 is the inhibition of host RNAP transcription, which apparently
becomes deleterious late in infection. The exact mechanism by
which host RNAP interferes with phage development is not known,
Fig. 1. Comparison of T7- and fKMV-subgroup phage genomes.The genome of T7 phage is schematically presented at the top and aligned with a phi15 (a T7-subgroup
Pseudomonas phage) and fKMV-subgroup Pseudomonas phages LKD16, LUZ19, and LKA1. In T7, genes belonging to different temporal expression classes (early, middle,
and late) are indicated. Some replication (dark green) and structural (dark blue) genes are homologous in all ﬁve genomes, as are the viral RNAP genes (yellow). Host RNAP
inhibitor genes are shown in red. Genes indicated by lighter shaded of green or blue are conserved within T7- of fKMV-subgroups only. Rightward arrows indicate viral
RNAP promoters, known (for T7) or predicted18 (for LKD16).
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dispensable (Qimron et al., 2008; Savalia et al., 2010). It has been
proposed that when the slower moving host RNAP transcribes into
extended middle and late gene clusters of the phage, it becomes an
obstacle to the much faster viral RNAP, causing the latter to stall
and recruit phage DNA packaging/concatemer cleavage machinery
at aberrant sites, leading to generation of less-than-unit length
non-functional phage genomes (Qimron et al., 2008).
T7 is a founding member of a very large clade of phages of the
Podoviridae family (Molineux, 2006). Many members of the family
(sometimes referred to as ‘‘the T7 supergroup’’ (Hardies et al., 2003)
and now formally classiﬁed as the Autographivirinae subfamily within
the ICTV IXth report) encode a single-subunit viral RNAP. While some
phages, belonging to the T7-subgroup, are very similar to T7 in their
genomic organization and likely share a common strategy of infec-
tion, others are quite different. In particular, a clearly distinct
subgroup, named after the Pseudomonas aeruginosa fKMV phage
(Lavigne et al., 2003; Ceyssens et al., 2006) was described. Phages
from this group infect bacteria of the Pseudomonas genus and differ
from T7 and its close relatives in several respects, most obviously in
the position of the viral RNAP gene. In fKMV-like phages, the viral
RNAP gene is located close to the middle of the genome, between the
replication and structural gene clusters (Fig. 1). Therefore, the process
of phage DNA injection in host cell, and the temporal control of gene
expression of fKMV-like phages must differ signiﬁcantly from those
operating in the T7 subgroup. In fact, no homologs of T7 gene 2 are
listed in available annotations of fKMV-related phage genomes
(Lavigne et al., 2003; Ceyssens et al., 2006; Kulakov et al., 2009).
However, since fKMV-like phages probably rely on viral RNAP
transcription for expression of at least their structural genes, one
can hypothesize that a host RNAP inhibitor(s) either analogous or
homologous to gp2 proteins encoded by T7 subgroup phages may be
also encoded by fKMV-related phages. In this paper we identify host
RNAP inhibitors encoded by fKMV-like phages and show that these
proteins share a common RNAP binding site with T7 gp2 and canfunctionally substitute for T7 gp2 during the infection. We propose
that most, or, perhaps, all phages encoding their own RNAP, also
encode inhibitors of host RNAP that ensure orchestrated transcription
of phage genes during the infection.Results
Identiﬁcation of phage proteins interacting with pseudomonas RNAP
in cells infected with fKMV-like phages
Co-afﬁnity puriﬁcation coupled with mass spectrometric identiﬁ-
cation is a powerful method to identify unknown phage proteins
binding to host RNAP (Savalia et al., 2008; Westblade et al., 2008).
To apply this approach to fKMV-like phages, we constructed a
P. aeruginosa rpoC::PrA strain encoding a Protein A tag attached to
the C-terminal end of the RNAP b0 subunit. The strain was viable and
indistinguishable from parental wild-type strain at laboratory condi-
tions. The strain was infected with fKMV-like phages LKA1 or LUZ19
(Ceyssens et al., 2006), cells were harvested 10min post-infection
and processed for afﬁnity puriﬁcation of RNAP. Mass-spectrometric
identiﬁcation revealed the presence of Es70 components (RNAP a, b,
b0, o, and s70) and host transcription factor NusA. In addition
peptides from phage LKA1 protein gp36 and LUZ 19 gp25.1 were
also detected (Supplementary Tables 1 and 2), indicating that these
proteins might interact with host RNAP in infected cells.
Bioinformatic prediction of fKMV-like phage proteins similar
to T7 gp2
Phage LKA1 protein gp36 and phage LUZ19 gp25.1 are small
proteins that, according to available annotations, have no simi-
larity to proteins of known function in public databases.
C-terminal parts of both proteins are similar to each other
and both proteins are encoded by genes located immediately
Table 1
Complementation of T7 2 am growth defect by overproduction of plasmid-encoded
T7 gp2 or similar Pseudomonas phage proteins.
Host E.O.P. Size of plaques
E. Klimuk et al. / Virology 436 (2013) 67–74 69upstream of respective viral RNAP genes (Fig. 1). Similar proteins
are encoded by other known fKMV-like phages (Fig. 1). While a
PSI-BLAST search of NCBI NR database with default parameters
using T7 gp2 sequence (GI: 9627441) as a query does not retrieve
any similar sequences from phages of the fKMV group (Ceyssens
et al., 2006), more careful analysis presented below predicts that
LKA1 gp36 and LUZ19 gp25.1 are related to T7 gp2. When gp2
homolog from T7-like Pseudomonas phage phi15, (GI: 326424972)
is used as a query and the search is performed only for database
subset representing sequences from Caudovirales with the PSI-
BLAST parameters modiﬁed for small proteins (see details in
Material and Methods), a sequence of fKMV-like Pseudomonas
phage LKD16 gp25b (GI: 158345052) is retrieved with statistically
signiﬁcant E-value of 9105. A search started from the latter
sequence identiﬁes homologs in all available genomes of phages
from the fKMV subgroup infecting P. aeruginosa. Identiﬁed
proteins include LKA1 gp36 and LUZ19 gp25.1 that, based on
co-puriﬁcation data (above), interact with host RNAP. Initial
analysis failed to identify a protein similar to T7 gp2 encoded
by fKMV, the prototypical member of the phage group analyzed
here. However, more careful analysis revealed that published
annotation (Lavigne et al., 2003) has overlooked a fKMV ORF
between nucleotide positions 17880–18024 (AJ505558) that
codes for a protein identical to LKD16 gp25b.
We selected non-identical sequences detected by PSI-BLAST
searches to build a multiple alignment using MUSCLE program
(see Supplementary Figure 1). An alignment of T7 gp2 with a
subset of predicted homologs from phi15 gp16, LKD16 gp25b
(identical to gp28 encoded by phage PT5, GI: 195546669 and the
fKMV protein missed in the original annotation), LUZ19 gp25.1
(GI: 167600471, identical to phiKF77 gp29, GI: 225626352), and
LKA1 gp36 (GI: 158345170) is presented in Fig. 2. As can be seen,
a putative homolog from LUZ19 (gp25.1) is considerably longer
than other proteins, with a sequence similar to T7 gp2 located at
its C-terminal end. The 60 aminoacid N-terminal extension of
gp25.1 has no similarity to protein sequences in public databases.IJ511 (Su) 1 þþþ
MG1655 (wt) 0 –
MG1655þpET33-gp2 (T7) 1 þþþ
MG1655þpET19-gp16 (phi15) 1 þþþ
MG1655þpET19-gp25 (LKD16) 1 þþþ
MG1655þpET19-gp25.1 (LUZ19) 1 þþþ
MG1655þpET19-gp25.1 short (LUZ19) 1 þþþ
MG1655þpET19-gp25.1 SC (LUZ19) 0 –
MG1655þpET19-gp36 (LKA1) 0 –
MG1655þpET19-gp36short (LKA1) 0.5 þ
MG1655þpET19-gp36 C4A (LKA1) 0.5 þ
MG1655þpET19-gp36 C7A (LKA1) 0.5 þ
MG1655þpET19-gp36 C4A C7A (LKA1) 0.5 þ
200 plaque forming units of T7 2am were plated on lawns of E. coli strains with or
without indicated plasmids (column 1) and after overnight growth efﬁciency of
plating (column 2, deﬁned as the ratio of plaques formed on indicated cell lawns
to the number of plaques formed on suppressing strain IJ511) and the size of
phage plaques (column 3) was recorded. ‘‘ ’’ indicates no visible plaques present;
‘‘þ ’’ indicates plaques less than 1 mm in diameter, while ‘‘þþþ ’’ indicates plaques,
with diameter of more than 3 mm.Gp2-like proteins encoded by pseudomonas phages complement
the growth of T7 gene 2 amber mutant
T7 with an amber mutation in gene 2 does not form plaques on
lawns of non-suppressing MG1655 E. coli cells due to strongly
decreased burst size (LeClerc and Richardson, 1979). The mutant
phage plates normally on a suppressing strain IJ511 (Table 1).
When the host contains a wild-type copy of gene 2 on a pET
expression plasmid, plaques of normal size form (Ca´mara et al.,
2010; Table 1). The plasmid-borne gene 2 is transcribed from a
promoter recognized by T7 RNAP. The plasmid-borne gene is thus
not transcribed in uninfected host, however, during the infection,
transcription of plasmid-borne gene 2 by virus-encoded RNAP
occurs, followed by complementation of growth defect. Genes
coding for predicted gp2-like proteins from Pseudomonas phagesFig. 2. Multiple sequence alignment of T7 gp2 with putative homologs from Pseudomo
aligned with similar sequences from indicated Pseudomonas phages. The alignment was
degree of conservation; hyphens indicate gaps. For proteins from LUZ19 and LKA1, arr
position of the amber codon introduced in the long version of gp25.1, as well as the sites
details). Red and blue asterisks above the T7 gp2 sequence indicate T7 gp2 residues im
references to colour in this ﬁgure legend, the reader is referred to the web version ofwere cloned into pET plasmid vectors, plasmids were introduced
into non-suppressing E. coli cells, and the ability of T7 carrying an
amber mutation in gene 2 to form plaques on lawns formed by
these cells was determined. The results, presented in Table 1,
demonstrate that cells carrying plasmid-borne genes from phi15,
LKD16, and LUZ19, but not from LKA1, complemented the growth
defect of the mutant phage. The result thus suggests that the
products of phi15, LKD16, and LUZ19 genes may act as inhibitors
of E. coli RNAP. The result with the phi15 product is an expected
one, since this protein is very similar to the gp2 homolog encoded
by Pseudomonas phage gh1 (Kovalyova and Kropinski, 2003),
which we previously showed to inhibit transcription by E. coli
and P. aeruginosa RNAP in vitro through the same mechanism as
T7 gp2 (Nechaev et al., 2003). The result with LKD16 and LUZ19
products suggests that phages of the fKMV subgroup also encode
a host RNAP inhibitor. This conclusion, however, appears to be
incompatible with the fact that the LKA1 protein gp36, which is
clearly related to LUZ19 and LKD16 proteins, does not comple-
ment T7 2am growth. Inspection of the LKA1 gp36 sequence
(Fig. 2) reveals the presence of a short N-terminal extension that
is absent in other proteins. We hypothesized that this extension
may affect the ability of the C-terminal part of the protein to
inhibit E. coli RNAP. Accordingly, pET plasmid expressing gp36
lacking the N-terminal extension (gp36-short, starting with
methionine corresponding to Leu16 of the full-length protein)
was created and tested for complementation. Partial complemen-
tation of T7 2am defect was observed on cell lawns expressing the
shortened version of the protein (plaques of o1 mm diameternas phages. The T7 gp2 sequence presented at the top (single aminoacid code) is
prepared using the GENEDOC software. Intensity of the background corresponds to
ows indicate the positions from which shorter versions of the proteins began. The
of aminoacid substitutions of gp36 N-terminal cysteines are indicated (see text for
portant for RNAP binding and inhibition, respectively. (For interpretation of the
this article.)
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sing T7 gp2).
The N-terminal extension of gp36 contains four cysteine
residues that may bind a metal ion, potnetially forming a Zn-
ﬁnger-like structure. Plasmids expressing gp36 versions with
substitutions of cysteine residues for alanines (C4A, C7A, and a
double mutant C4A C7A) were created and tested for comple-
mentation. Cells harboring the mutant gp36 expression plasmids
complemented the growth defect of T7 2am phage to the same
extent as cells expressing a truncated version of the protein
(Table 1). We therefore conclude that the N-terminal extension
of bacteriophage LKA1 gp36 protein negatively modulates its
ability to inhibit E. coli RNAP. We speculate that this modulation
may be dependent on gp36 ability to chelate metal ions.
If its N-terminal extension affects the ability of gp36 to inhibit
bacterial RNAP, then one needs to regard complementation data
with LUZ19 gp25.1, a much longer protein, with caution, since it
is possible that complementation observed is due to a shorter
protein synthesized from an internal translation initiation site.
Indeed, cells harboring a plasmid expressing the C-terminal part
of gp25.1 (‘‘gp25.1 short’’, amino acids 60–121) fully comple-
mented the growth of T7 2am phage (Table 1). To determine
whether a short version of gp25.1 is indeed responsible for
complementation of mutant T7 growth in cells harboring a
plasmid expressing full-length gp25.1, an expression plasmid
with LUZ19 gene 25.1 containing an amber codon at position 59
was created. The stop codon was expected to prevent the synth-
esis of the longer version of gp25.1 but should have had no effect
on the short version production if such version existed. As can be
seen from Table 1, cells harboring such a plasmid did not support
the growth of T7 2am phage. The result thus proves that the longer
version of gp25.1 is solely responsible for complementation
observed. This conclusion agrees with MS/MS identiﬁcation that
revealed a peptide corresponding to LUZ19 gp25.1 residues 46–57
in afﬁnity puriﬁed RNAP from infected P. aeruginosa cellsFig. 3. Transcription inhibition by T7 gp2 and Pseudomonas phage proteins. E. coli (A) or
with 5xfold molar excess of indicated phage proteins followed by the addition of T7
initiation reaction (CpA and a-32 P-UTP). Reaction products were revealed after dena
synthesized in the presence of phage protein compared to the amount of product syn
amounts of indicated phage proteins were added to P. aeruginosa RNAP and then anal(Supplementary Table 3). This peptide is present in full-sized
gp25.1 but absent from the shorter version. Overall, analysis of
gp25.1 indicates that N-terminal extensions as such have no effect
on T7 gp2 homologs ability to inhibit E. coli RNAP, lending further
support to a notion that a speciﬁc structure adopted by the four-
cysteine containing N-terminal extension of gp36 is responsible for
its apparent inactivity in the complementation assay.
E. coli cells JE1134 harbor a deletion of RNAP b0 residues 1149–
1190 (Ederth et al., 2002). The deletion destroys the T7 gp2
binding site, the b0 downstream jaw, and thus mimics the absence
of gp2 (Savalia et al., 2010). As a result JE1134 cells are not-
permissive for wild-type T7. Likewise, E. coli 7009 cells, harboring
a charge altering E1188K substitution in the b0 subunit, are also
non-permissive to gp2, since the mutation prevents the interac-
tion of gp2 with its target (Nechaev and Severinov, 1999). JE1134
or 7009 cells harboring T7 gp2 overproduction plasmid did not
complement the growth of T7þ , as expected. Likewise, wild-type
T7 was unable to form plaques on lawns of JE1134 or 7009 cells
overproducing gp2-like proteins encoded by Pseudomonas phages
(data not shown). The results suggest that T7 gp2 and gp2-like
proteins encoded by Pseudomonas phages have a common binding
site on E. coli RNAP, which is destroyed by deletion or charge-
altering substitutions in the b0 jaw.Pseudomonas phage proteins inhibit transcription in vitro
The results of in vivo analyses are consistent with bioinformatic
predictions. However, because the growth defect of T7 2am can be
complemented by any host RNAP inhibitor, for example, by the
addition of rifampicin at the end of the early transcription stage
(Ontell and Nakada, 1980; Mooney et al., 1980), the results do not
exclude that some of Pseudomonas phage proteins inhibit host RNAP
by a mechanism that is distinct from T7 gp2 inhibition mechanism.
To address this possibility, phage proteins were puriﬁed and theirP. aeruginosa (B) RNAPs supplemented with E. coli s70 subunit were preincubated
A1 promoter-containing DNA fragments and substrates for abortive transcription
turing gel-electrophoresis. The residual activity (amount of the CpApU product
thesized by RNAP alone) is presented below (in %). In panels C and D increasing
yzed as described above.
E. Klimuk et al. / Virology 436 (2013) 67–74 71ability to inhibit RNAPs puriﬁed from P. aeruginosa PAO1, and wild-
type E. coli RNAP was investigated. To ensure that afﬁnity tags used
for protein puriﬁcation do not affect protein function, the tags were
removed by treating recombinant puriﬁed proteins with thrombine,
a speciﬁc protease whose cleavage site is located at the boundary
between the afﬁnity tag and phage protein sequence. All phage
proteins were present in a 5-fold excess over RNAPs. None of phage
proteins tested had any effect when added to preformed wild-type
E. coli or P. aeruginosa open promoter complexes (data not shown).
The results obtained when phage proteins were combined with
RNAP prior to the addition of DNA and transcription substrates are
shown in Fig. 3. The data can be summarized as follows. First, T7
gp2 efﬁciently inhibited transcription by both E. coli and P. aerugi-
nosa RNAPs (Fig. 3AB, compare lanes 1 and 2). Gp25b, and the short
versions of gp25.1 and gp36 were also efﬁcient (less than 10%
residual activity) inhibitors of transcription by P. aeruginosa RNAP
(Fig. 3B, lanes 4, 6, and 8, correspondingly). These proteins appeared
to be less efﬁcient inhibitors of the E. coli enzyme (430% of residual
activity, Fig. 3A) in line with earlier observations with the gp2
homolog from phage gh1, which suggested that the interaction with
cognate Pseudomonas RNAP is stronger than with non-cognate
enzyme from E. coli (Nechaev et al., 2003). Under the conditions
used, the long versions of gp25.1 and gp36 had no effect on E. coli
RNAP transcription (Fig. 3A, lanes 5 and 7, correspondingly) but
partially inhibited the Pseudomonas enzyme. Somewhat unexpect-
edly, phi15 gp16, which is the most closely related to T7gp2, was a
relatively poor in vitro inhibitor of both E. coli and P. aeruginosa
enzymes (Fig. 3AB, lane 3).
Increasing the concentration of full-sized gp36 up to a
50-excess over RNAP did not lead to transcription inhibition
(Fig. 3C). In contrast, when higher concentrations of full-sized
gp25.1 were used, complete inhibition of transcription by P.
aeruginosa RNAP was achieved (Fig. 3D). A shortened version of
gp36, as well as the C4A mutant, were highly active in transcrip-
tion inhibition (Fig. 3C), in agreement with in vivo data.Analysis of pseudomonas phage proteins binding to RNAP
To determine whether Pseudomonas phage proteins share the
RNAP binding site with T7 gp2, terminally 32P-labeled version of
LKD16 gp25b protein was prepared by phosphorylation of the
N-terminal heart muscle kinase (HMK) tag. During native PAGE
analysis, radioactively labeled LKD16 gp25b interacted with
P. aeruginosa RNAP as evidenced by formation of a low-mobility
radioactive band in the presence of RNAP and the absence of radio-
active band corresponding to free LKD16 gp25b (Fig. 4, compareFig. 4. Binding of phage proteins to P. aeruginosa RNAP.32 P-labeled gp25b alone
(lane 1) or with P. aeruginosa RNAP (lane 2) was separated by native gel
electrophoresis. In lanes 3–9, reactions contained indicated unlabeled phage
proteins present in 5-fold excess over 32 P-labeled gp25b.lanes 1 and 2). When a 5-fold excess of unlabeled T7 gp2, phi15 gp16,
or LKD16 gp25b was added to reactions containing RNAP and
radioactive gp25b, the intensity of the shifted band decreased, and
free radioactive gp25b band reappeared (lanes 3, 4, and 5, corre-
spondingly). The results thus prove that the binding of LKD16 gp25b
and T7 gp2/phi15 gp16 to RNAP is mutually exclusive. Under the
conditions of the experiment, full-sized versions of gp25.1 or gp36
were unable to compete with radioactive LKD16 gp25b (lanes 6 and
8, correspondingly), in agreement with in vitro transcription results
shown in Fig. 3A. However, the shorter versions of both proteins
competed as efﬁciently as LKD16 gp25b, T7 gp2 or phi15 gp16 (lanes
7 and 9). We therefore conclude that the Pseudomonas phage proteins
and T7 gp2 share a common binding site on the RNAP.Discussion
In this communication, we show that several previously
uncharacterized gene products of fKMV-related P. aeruginosa
podophages of the T7 supergroup are functional equivalents of
bacteriophage T7 gp2 inhibitor of host RNAP. In vivo assays reveal
that some proteins from fKMV-related phages complement the
growth defect of T7 phage carrying an amber mutation in gene 2,
provided that the gp2 binding site—the downstream jaw of E. coli
RNAP–is intact. In vitro, some proteins from fKMV-related phages
inhibit transcription by P. aeruginosa and E. coli RNAPs and
compete with T7 gp2 for the binding to RNAP. Preformed open
promoter complexes are resistant to inhibition by both T7 gp2
and fKMV-related phage proteins. Overall, the data strongly
suggest that transcription inhibitors encoded by fKMV-related
phage proteins and T7 gp2 have a common transcription inhibi-
tion mechanism and act through the same RNAP binding site.
Though our data indicate that host RNAP inhibitors encoded by
fKMV-related phages and T7 gp2 are also similar by sequence,
the question about their homology (origin from a common
ancestor) remains open. Secondary structure predictions for gp2
and its close relatives from the T7 subgroup are in very good
agreement with T7 gp2 structure determined by NMR (Supple-
mentary Fig. 1). In contrast, transcription inhibitors encoded by
fKMV-related phages have predicted secondary structures that
are radically different from the T7 gp2 secondary structure
(Supplementary Figure 1). Cases of homologous proteins assum-
ing different structures have been described, including transcrip-
tion factor NusG and its paralog RfaH that also interact with RNAP
(Belogurov et al., 2007; Bryan and Orban, 2010). Thus, structure
determination of one of the fKMV subgroup proteins is of
considerable interest and is currently underway in our laboratory.
At least two Pseudomonas phage proteins, gp25.1 from LUZ19
and gp36 from LKA1, clearly differ from T7 gp2. These proteins
are either much longer than T7 gp2 (gp25.1) or contain an
N-terminal extension which might form a Zn2þ binding site.
The )extra* sequences in both proteins appear to interfere with
the RNAP inhibition by the C-terminal domain homologous to T7
gp2. In the case of gp36, substitution of cysteine residues that
could chelate Zn2þ for alanines restores the RNAP inhibitory
activity. It is attractive to speculate that N-terminal domains of
gp36 (and, possibly, gp25.1) act as receiver modules that allow
these proteins to bind to and inhibit the host RNAP at a precise
time during post-infection. The nature of the environmental
cue(s) that leads to this hypothetical activation of RNAP inhibition
by longer proteins encoded by some fKMV-related phages
remains to be determined. While the N-terminal extension of
gp25.1 appears to simply decrease the efﬁciency of gp2-like
domain interaction with (and inhibition of) RNAP, a much shorter
N-terminal extension of gp36 completely prevents its inhibitory
activity in vitro and in a heterologous E. coli host in vivo. Removing
E. Klimuk et al. / Virology 436 (2013) 67–7472this extension or substituting one of the four cysteine residues
makes gp36 a highly efﬁcient inhibitor of E. coli or P. aeruginosa
RNAP transcription in vitro, yet the mutant proteins still only
partially complement the growth defect of T7 2am.
The essential function of T7 gp2, and, presumably, of homologs
encoded by T7 subgroup phages, is to prevent transcription of
phage middle and late genes by host RNAP, which interferes with
the viral RNAP transcription. The role of host RNAP inhibitors
encoded by fKMV-related phages infecting P. aeruginosa must be
different, as follows from the central position of the viral RNAP
gene in these phages genomes, between viral replication (corre-
sponding to middle T7 genes) and virion (corresponding to T7 late
genes) gene clusters. If gp2-like proteins encoded by fKMV-
related phages act as switch factors between host and viral RNAP,
they should control a switch from early and middle genes
transcription (presumably performed by host RNAP) to late gene
transcription performed by viral RNAP.
Available data indicate that among the phages encoding their
own RNAP, members of the T7 subgroup, the Xp10-like phages of
Xanthomonas (Nechaev et al., 2002), and now the fKMV-related
phages of P. aeruginosa encode inhibitors of host RNAP. RNAP-
encoding phages such as the Salmonella phage SP6, a podovirus,
and E. coli phage phiEcoM-GJ1 (Jamalludeen et al., 2008),
a myovirus, are not known to encode host RNAP inhibitors.
We hypothesize that these and other phages encoding their
own RNAP encode host transcription inhibitors and could be thus
a source of new factors affecting host transcriptional apparatus.Materials and methods
Afﬁnity puriﬁcation of bacterial RNAP
A 300 ml culture of P. aeruginosa PAO1 cells carrying genomic
rpoC::Protein A fusion was infected at 37 1C with phage at multi-
plicity of infection of 10. The infection was terminated 10 min
later by rapidly cooling infected cultures. Cells were harvested by
centrifugation, washed once with ice-cold 10% (v/v) glycerol, and
dissolved in 10 ml Protein A buffer [10 mm Tris.HCl pH 8, 150 mm
NaCl, 0.1% (v/v) NP-40] supplemented with 100 ml Protease
Inhibitor Mix (Amersham Biosciences), 10 mm Benzonase (Novagen),
10 mg lysozyme (Sigma) and 800 ml 10x BugBuster (Novagen).
This mixture was incubated at room temperature for 15 min with
gentle agitation. The soluble fraction was isolated by two successive
30-min centrifugation steps at 27,200x g at 4 1C. Subsequently, this
fraction was incubated with 200 ml pre-washed IgG SepharoseTM
6 Fast Flow beads (GE Healthcare) with gentle agitation for 2 h at
4 1C. The beads were collected in Bio-Rad Poly-Prep s Chromato-
graphy column and washed three times with Protein A buffer. The
beads were incubated in ProTEV Protease (Promega) in the supplied
buffer, and transferred to a smaller HandeeTM Spin Column (Pierce)
for overnight incubation at 4 1C. The beads were washed twice with
Protein A buffer, and all eluates were pooled. The eluted proteins
were re-dissolved in 6 M urea/2 M thiorea/10 mm HEPES pH 8.0.
Disulﬁde bounds were reduced by 1mm dithiothreitol, alkylated
with 5.5 mm iodoacetamide, and proteins were digested overnight at
37 1C using modiﬁed sequencing grade trypsin (1:50 w/w) after 4-
fold diluting the sample with 50 mmNH4HCO3. Digestion was halted
by the addition of triﬂuoroacetic acid (TFA) to a ﬁnal concentration of
1%. Peptides were puriﬁed using reversed-phase Sep-Pak C18 peptide
puriﬁcation cartridges, and eluted in 50% acetonitrile/0.1%TFA. The
eluates were separated over 130 min on an analytical column (Bio-
sphere C18; NanoSeparations) using a linear gradient from 5 to 60%
(v/v) ACN in water containing 100 mm acetic acid. Material eluting
from the column was introduced by a nanoelectrospray device and
sprayed from a gold-coated fused silica emitter (NanoSeparations).The MS was operated in a data-dependent acquisition mode to
automatically switch between MS (m/z 300–1500) and MS/MS
acquisition on the three most intense precursor ions, controlled by
Xcalibur 1.3 software. MS/MS data were analyzed using Sequest
(Thermoﬁnningan) against a local stop-to-stop database of all
possible phage proteins allowing 1 Da fragment tolerance. Peptide
hits were considered signiﬁcant at minimal cross-correlation values
of 1.8, 2.5 and 3.5 for single, double and triple charged peptide ions,
respectively.
Sequence analysis
PSI-BLAST (Altschul et al., 1997) was used to search for gp2
homologs in NCBI NR database or a subset containing only
sequences from the Caudovirales. The search against sequences
from Caudovirales was adjusted as follows: expect threshold was
set to 100; inclusion threshold 0.001; gap cost parameter exis-
tence 9/extension 2; word size 2; no composition based statistics
and low complexity ﬁltering were applied. Multiple alignment of
the sequences detected by PSI-BLAST was constructed using the
Muscle program (Edgar, 2004) with default parameters. Second-
ary structure was predicted using Jpred (Cole et al., 2008) and
PSIPRED (Buchan et al., 2010) programs.
Bacterial strains, phage, and growth conditions
The wild-type bacteriophage T7þ and T7 2am carrying and an
amber mutation at gene 2 codon 16 were the same as used in the
previous work (Savalia et al., 2010). E. coli K-12 strains MG1655
(F- lambda- ilvG- rfb-50 rph-1) and a Suþ strain IJ511 (DlacX74
supE44 galK2 galT22 mcrA rfbD1 mcrB1 hsdS3) were used to
propagate the phage.
Cells were grown in standard LB media at 37 1C. To prepare T7
lysates a single plaque was added to 100 ml LB of IJ511 culture
grown at 37 1C to mid-log phase (A600 0.3-0.4) and infection was
allowed to proceed for 10 h 37 1C. Phage particles were separated
from cell debris by the addition of NaCl to 0.5 M, brief shaking,
and centrifugation at 10,000 g at þ4 1C for 15 min. The resulting
lysate had a titer of 2–5 1010 p.f.u./ml and was stored at þ4 1C.
Plasmids
A pET33-based plasmid expressing T7 gene 2 was described
previously (Ca´mara et al., 2010). Plasmids expressing Pseudomo-
nas phage genes were created by cloning PCR fragments ampliﬁed
from phage genomic DNA with appropriate primers into the
multiple cloning site of a pET19-derived vector plasmid. The
pET19 commercial vector was modiﬁed by site-speciﬁc mutagen-
esis to incorporate a sequence coding for an in-frame HMK tag
between the sequence coding for N-terminal histidine tag and the
NdeI site used for cloning phage ORFs. Both tags can be removed
by treating recombinant protein according to manufacturer
(Novagene) recommendations.
Phage growth complementation assays
E. coli K-12 MG1655 was transformed with expression plas-
mids containing cloned genes coding for gp2-like proteins. Trans-
formants were grown at 37 1C in LB until A600 0.4–0.8. 100 ml of
T7 2am phage lysate dilution corresponding to 200 plaque-
forming units on IJ511 strain was added to 100 ml cell culture
aliquots. After the addition of 4 ml of melted 0.4% LB
the infections were overlaid on LB agar plates. Plates were
incubated at 37 1C for 10 h and phage plaques were enumerated.
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An E. coli strain JE1134 encoding a T7 gp2-resistant RNAP with
deletion of residues 1149–1190 in the b0 jaw domain (Ederth
et al., 2002) lysogenized with l(DE3) phage was used for expres-
sion of all phage proteins, since most proteins are toxic when
expressed in wild-type DE3 lysogens. Transformants were grown
in LB supplemented with 100 mg/ml of ampicillin to A600 of 0.3–
0.5 and expression of plasmid-borne phage genes was induced by
the addition of IPTG to 1 mm. After three hours of additional
growth, cells were harvested by centrifugation and resuspended
in buffer A (20 mm Tris–HCl (pH 8.0), 0.05 M NaCl, 0.5 mM
b-mercaptoethanol, 5% glycerol) with 1 mg/ml lysozyme. After
1-h incubation on ice, cells were disrupted by sonication. All
recombinant proteins segregated in inclusion bodies. Inclusion
bodies were resuspended in buffer B (20 mM Tris–HCl (pH 8.0),
0.5 M NaCl, 8 M urea, 0.5 mM b-mercaptoethanol, 5% glycerol).
After 1-h incubation at room temperature with occasional mixing,
the solution was ﬁltered through Acrodiscs 0.45 Syringe ﬁlter
and applied on a 1 ml chelating HiTrap column (GE Healthcare)
charged with Ni2þ . The column was washed with buffer B
containing 50 mM imidazole and bound proteins were eluted
with buffer B containing 250 mM imidazole. Fractions containing
gp2-like proteins were dialyzed into buffer S (20 mM Tris-Cl (pH
8.0), 200 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 10 mM MgCl2,
10 mM ZnCl2 and 20% glycerol) overnight, concentrated on
Centricons Centrifugal Filter Units (Millipore), supplemented
with glycerol to the ﬁnal concentration of 50% and resulting
proteins (at least 95% pure) were stored at 20 1C.
All RNAPs used in this work were prepared essentially as
described previously (Borukhov and Goldfarb, 1993; Kashlev
et al., 1996).
In vitro transcription assays
10 ml standard reactions contained of 100 nM Es70, 20 nM
promoter DNA, 0.5 mM dinucleotide primer CpA, 0.4 mCi of
[a-32 P]UTP in buffer R (40 mM Tris–HCl, 40 mM KCl, 10 mM
MgCl2, 5 mM DTT, 100 mg/ml BSA). Unless stated otherwise, phage
proteins and Es70 were always preincubated before the addition
of promoter DNA. Reactions were allowed to proceed for 10 min
at 37 1C and were terminated by the addition of an equal volume
of denaturing loading buffer. The reaction products were resolved
on a denaturing 6 M urea 20% (w/v) polyacrylamide gels and
visualized using a PhosphorImager.
Native gel mobility assays
Native mobility shift assays and 32P labeling of gp25b were
conducted essentially as described previously by Ca´mara et al.,
(2010) for T7 gp2. Binding reactions (10 ml) were set up in buffer
R at 37 1C and analyzed on a 6% native polyacrylamide gels. The
gel was run for 60 min at 100 V. Proteins or protein complexes
were visualized and quantiﬁed using a PhosphorImager.Acknowledgments
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